Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest. (Q44475259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Francisco José Nicolás

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Francisco J Nicolás

series ordinal

1

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

3698-3711

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12802277%20AND%20SRC:MED&resulttype=core&format=json

Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Synergism between transcription factors TFE3 and Smad3 in transforming growth factor-beta-induced transcription of the Smad7 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

A quantitative analysis of signal transduction from activin receptor to nucleus and its relevance to morphogen gradient interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

TGF-beta signaling: positive and negative effects on tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

Smithsonian closure plan under fire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

Morphogen gradient interpretation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021

Biosynthesis of the type I and type II TGF-beta receptors. Implications for complex formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206420

7 January 2021